Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 232836, 7 pages
http://dx.doi.org/10.1155/2015/232836
Research Article

Direct Effects of (−)-Epicatechin and Procyanidin B2 on the Respiration of Rat Heart Mitochondria

1Department of Pharmaceutical Technology and Social Pharmacy, Medical Academy, Lithuanian University of Health Sciences, Eiveniu 4, LT-50161 Kaunas, Lithuania
2Department of Pharmaceutics, University of Veterinary and Pharmaceutical Sciences Brno, Palackeho 1/3, 612 42 Brno, Czech Republic
3Department of Biochemistry, Medical Academy, Lithuanian University of Health Sciences, Kaunas, A. Mickeviciaus 9, LT-44307 Kaunas, Lithuania

Received 27 November 2014; Accepted 3 February 2015

Academic Editor: Min Li

Copyright © 2015 Dalia M. Kopustinskiene et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. S. M. Prince, “(−) Epicatechin prevents alterations in lysosomal glycohydrolases, cathepsins and reduces myocardial infarct size in isoproterenol-induced myocardial infarcted rats,” European Journal of Pharmacology, vol. 706, no. 1–3, pp. 63–69, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Galleano, I. Bernatova, A. Puzserova et al., “(–)-Epicatechin reduces blood pressure and improves vasorelaxation in spontaneously hypertensive rats by NO-mediated mechanism,” IUBMB Life, vol. 65, no. 8, pp. 710–715, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Schroeter, C. Heiss, J. Balzer et al., “(-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 4, pp. 1024–1029, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. C. G. Fraga and P. I. Oteiza, “Dietary flavonoids: role of (-)-epicatechin and related procyanidins in cell signaling,” Free Radical Biology and Medicine, vol. 51, no. 4, pp. 813–823, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. E. J. B. Ruijters, A. R. Weseler, C. Kicken, G. R. M. M. Haenen, and A. Bast, “The flavanol (-)-epicatechin and its metabolites protect against oxidative stress in primary endothelial cells via a direct antioxidant effect,” European Journal of Pharmacology, vol. 715, no. 1–3, pp. 147–153, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. M. M. Avelar and C. M. C. P. Gouvêa, “Procyanidin B2 cytotoxicity to MCF-7 human breast adenocarcinoma cells,” Indian Journal of Pharmaceutical Sciences, vol. 74, no. 4, pp. 351–355, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. W.-Y. Zhang, H.-Q. Liu, K.-Q. Xie et al., “Procyanidin dimer B2 [epicatechin-(4β-8)-epicatechin] suppresses the expression of cyclooxygenase-2 in endotoxin-treated monocytic cells,” Biochemical and Biophysical Research Communications, vol. 345, no. 1, pp. 508–515, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Sakano, M. Mizutani, M. Murata, S. Oikawa, Y. Hiraku, and S. Kawanishi, “Procyanidin B2 has anti- and pro-oxidant effects on metal-mediated DNA damage,” Free Radical Biology and Medicine, vol. 39, no. 8, pp. 1041–1049, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. O. Ertracht, A. Malka, S. Atar, and O. Binah, “The mitochondria as a target for cardioprotection in acute myocardial ischemia,” Pharmacology & Therapeutics, vol. 142, no. 1, pp. 33–40, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Kalogeris, Y. Bao, and R. J. Korthuis, “Mitochondrial reactive oxygen species: a double edged sword in ischemia/reperfusion vs preconditioning,” Redox Biology, vol. 2, pp. 702–714, 2014. View at Publisher · View at Google Scholar
  11. F. Tullio, C. Angotti, M.-G. Perrelli, C. Penna, and P. Pagliaro, “Redox balance and cardioprotection,” Basic Research in Cardiology, vol. 108, no. 6, article 392, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. J. L. Holtzman, “Calibration of the oxygen polarograph by the depletion of oxygen with hypoxanthine-xanthine oxidase-catalase,” Analytical Chemistry, vol. 48, no. 1, pp. 229–230, 1976. View at Publisher · View at Google Scholar · View at Scopus
  13. S. W. G. Tait and D. R. Green, “Mitochondria and cell death: outer membrane permeabilization and beyond,” Nature Reviews Molecular Cell Biology, vol. 11, no. 9, pp. 621–632, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Stanely Mainzen Prince, “Preventive effects of (-) epicatechin on altered adenosine triphosphatases and minerals in isoproterenol-induced myocardial infarcted rats,” Journal of Biochemical and Molecular Toxicology, vol. 26, no. 12, pp. 516–521, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. C. C. Leonardo, M. Agrawal, N. Singh, J. R. Moore, S. Biswal, and S. Doré, “Oral administration of the flavanol (-)-epicatechin bolsters endogenous protection against focal ischemia through the Nrf2 cytoprotective pathway,” European Journal of Neuroscience, vol. 38, no. 11, pp. 3659–3668, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. H. J. Heo and C. Y. Lee, “Epicatechin and catechin in cocoa inhibit amyloid beta protein induced apoptosis,” Journal of Agricultural and Food Chemistry, vol. 53, no. 5, pp. 1445–1448, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. G. N. Quiñonez-Bastidas, C. Cervantes-Durán, H. I. Rocha-González, J. Murbartián, and V. Granados-Soto, “Analysis of the mechanisms underlying the antinociceptive effect of epicatechin in diabetic rats,” Life Sciences, vol. 93, no. 17, pp. 637–645, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Ramirez-Sanchez, P. R. Taub, T. P. Ciaraldi et al., “(-)-Epicatechin rich cocoa mediated modulation of oxidative stress regulators in skeletal muscle of heart failure and type 2 diabetes patients,” International Journal of Cardiology, vol. 168, no. 4, pp. 3982–3990, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Ahmad, P. Khalid, M. M. Khan, A. K. Rastogi, and J. R. Kidwai, “Insulin like activity in (-) epicatechin,” Acta Diabetologica Latina, vol. 26, no. 4, pp. 291–300, 1989. View at Publisher · View at Google Scholar · View at Scopus
  20. W. T. Chang, Z. H. Shao, J. J. Yin et al., “Comparative effects of flavonoids on oxidant scavenging and ischemia-reperfusion injury in cardiomyocytes,” European Journal of Pharmacology, vol. 566, no. 1–3, pp. 58–66, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Moreno-Ulloa, A. Cid, I. Rubio-Gayosso, G. Ceballos, F. Villarreal, and I. Ramirez-Sanchez, “Effects of (-)-epicatechin and derivatives on nitric oxide mediated induction of mitochondrial proteins,” Bioorganic and Medicinal Chemistry Letters, vol. 23, no. 15, pp. 4441–4446, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Buitrago-Lopez, J. Sanderson, L. Johnson et al., “Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis,” British Medical Journal, vol. 343, Article ID d4488, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Panneerselvam, S. S. Ali, J. C. Finley et al., “Epicatechin regulation of mitochondrial structure and function is opioid receptor dependent,” Molecular Nutrition and Food Research, vol. 57, no. 6, pp. 1007–1014, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. P. S. M. Prince, “(-) Epicatechin attenuates mitochondrial damage by enhancing mitochondrial multi-marker enzymes, Adenosine triphosphate and lowering calcium in isoproterenol induced myocardial infarcted rats,” Food and Chemical Toxicology, vol. 53, pp. 409–416, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. A. K. Groen, R. J. Wanders, H. V. Westerhoff, R. van der Meer, and J. M. Tager, “Quantification of the contribution of various steps to the control of mitochondrial respiration,” The Journal of Biological Chemistry, vol. 257, no. 6, pp. 2754–2757, 1982. View at Google Scholar · View at Scopus
  26. J. W. Stucki, “The optimal efficiency and the economic degrees of coupling of oxidative phosphorylation,” European Journal of Biochemistry, vol. 109, no. 1, pp. 269–283, 1980. View at Publisher · View at Google Scholar · View at Scopus
  27. V. P. Skulachev, “Uncoupling: new approaches to an old problem of bioenergetics,” Biochimica et Biophysica Acta, vol. 1363, no. 2, pp. 100–124, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. F. M. Cunha, C. C. C. da Silva, F. M. Cerqueira, and A. J. Kowaltowski, “Mild mitochondrial uncoupling as a therapeutic strategy,” Current Drug Targets, vol. 12, no. 6, pp. 783–789, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Modrianský and E. Gabrielová, “Uncouple my heart: the benefits of inefficiency,” Journal of Bioenergetics and Biomembranes, vol. 41, no. 2, pp. 133–136, 2009. View at Publisher · View at Google Scholar
  30. R. P. Hafner, G. C. Brown, and M. D. Brand, “Analysis of the control of respiration rate, phosphorylation rate, proton leak rate and protonmotive force in isolated mitochondria using the ‘top-down’ approach of metabolic control theory,” European Journal of Biochemistry, vol. 188, no. 2, pp. 313–319, 1990. View at Publisher · View at Google Scholar · View at Scopus
  31. G. C. Brown, “Control of respiration and ATP synthesis in mammalian mitochondria and cells,” Biochemical Journal, vol. 284, part 1, pp. 1–13, 1992. View at Google Scholar · View at Scopus
  32. V. Borutaite, V. Mildaziene, G. C. Brown, and M. D. Brand, “Control and kinetic analysis of ischemia-damaged heart mitochondria: which parts of the oxidative phosphorylation system are affected by ischemia?” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1272, no. 3, pp. 154–158, 1995. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Minners, L. Lacerda, D. M. Yellon, L. H. Opie, C. J. McLeod, and M. N. Sack, “Diazoxide-induced respiratory inhibition—a putative mitochondrial KATP channel independent mechanism of pharmacological preconditioning,” Molecular and Cellular Biochemistry, vol. 294, no. 1-2, pp. 11–18, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Brossette, C. Hundsdörfer, K.-D. Kröncke, H. Sies, and W. Stahl, “Direct evidence that (-)-epicatechin increases nitric oxide levels in human endothelial cells,” European Journal of Nutrition, vol. 50, no. 7, pp. 595–599, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Ramirez-Sanchez, H. Aguilar, G. Ceballos, and F. Villarreal, “(-)-Epicatechin-induced calcium independent eNOS activation: roles of HSP90 and AKT,” Molecular and Cellular Biochemistry, vol. 370, no. 1-2, pp. 141–150, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Tanabe, Y. Tamura, M. A. Lanaspa et al., “Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy,” The American Journal of Physiology—Renal Physiology, vol. 303, no. 9, pp. F1264–F1274, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. K. G. Yamazaki, D. Romero-Perez, M. Barraza-Hidalgo et al., “Short- and long-term effects of (−)-epicatechin on myocardial ischemia-reperfusion injury,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 295, no. 2, pp. H761–H767, 2008. View at Publisher · View at Google Scholar · View at Scopus